NCT02299258

Brief Summary

gastric outlet obstruction tailored versus standard stents for malignant gastric outlet obstruction treatments

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2009

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2013

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

November 17, 2014

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 24, 2014

Completed
3 months until next milestone

Results Posted

Study results publicly available

February 12, 2015

Completed
Last Updated

February 12, 2015

Status Verified

February 1, 2015

Enrollment Period

3.8 years

First QC Date

November 17, 2014

Results QC Date

November 22, 2014

Last Update Submit

February 10, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Efficiency of Stents

    number of participants considered having efficacious outcome. Efficacy is defined by Ingrowth + overgrowth in this study

    up to 5 years

Secondary Outcomes (1)

  • Adverse Events

    up to 5 years

Study Arms (2)

Tailored stents MTN-WE-20/100-A

ACTIVE COMPARATOR

The distal portion of the GOO tailored stents was semi-spherical, with a length of 20 mm, and a diameter of 28 mm. The middle segment had a diameter of 20 mm. The overall length of the stents was 100 mm. Both the middle part and the bottom of the proximal cup segment, and a part of the proximal funnel segment, were covered by a polyethylene membrane.

Device: Tailored stents MTN-WE-20/100-A

Standard stents MTN-CG-s-20/100

EXPERIMENTAL

Standard uncovered stents were used in the control group. The ends of the stents were semi-spherical with diameters of 28 mm and length of 20 mm. The length of the stents was 100 mm

Device: Standard stents MTN-CG-s-20/100

Interventions

The ends of the stents were semi-spherical with diameters of 28 mm and length of 20 mm. The length of the stents was 100 mm

Standard stents MTN-CG-s-20/100

cup-shaped or funnel-shaped, according to the shapes of the proximal GOOs.

Tailored stents MTN-WE-20/100-A

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • GOO defined by symptoms resulting in decreased oral intake (nausea, vomiting and inability to eat),the obstruction was caused by primary distal stomach cancer and the site of stenosis was between the gastric body and duodenum bulb

You may not qualify if:

  • the presence of only mild symptoms in patients who could tolerate a liquid diet, clinical evidence of perforation or peritonitis, evidence of multiple small-bowel obstructions because of peritoneal seeding as well as diabetes or other diseases that affect gastric motility and use of promotility agents.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First People's Hospital of Yuhang District

Hangzhou, China

Location

MeSH Terms

Conditions

Gastric Outlet Obstruction

Condition Hierarchy (Ancestors)

Stomach DiseasesGastrointestinal DiseasesDigestive System Diseases

Results Point of Contact

Title
Dr.Ding Shi
Organization
The First People's Hospital of Yuhang District

Study Officials

  • Ding Shi

    The First People's Hospital of Yuhang District

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

November 17, 2014

First Posted

November 24, 2014

Study Start

May 1, 2009

Primary Completion

March 1, 2013

Study Completion

March 1, 2013

Last Updated

February 12, 2015

Results First Posted

February 12, 2015

Record last verified: 2015-02

Locations